Search Ontology:
ChEBI
baricitinib
- Term ID
- CHEBI:95341
- Synonyms
-
- 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile
- 2-(3-(4-(3H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
- baricitinib
- baricitinibum
- INCB 028050
- INCB-028050
- INCB028050
- LY 3009104
- LY-3009104
- LY3009104
- Olumiant
- {1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile
- Definition
- A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine substituted by a 1-[3-(cyanomethyl)-1-(ethanesulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl group at position 5. It is an FDA approved selective Janus Kinase 1 and 2 (JAK1 and JAK2) inhibitor used for the treatment of rheumatoid arthritis.
- References
-
- CAS:1187594-09-7
- Chemspider:26373084
- DrugBank:DB11817
- HMDB:HMDB0248873
- KEGG:D10308
- LINCS:LSM-6709
- PDBeChem:3JW
- PMCID:PMC8606629
- PMID:26853940
- PMID:27910962
- PMID:30036348
- PMID:30871014
- PMID:30907116
- PMID:32856090
- PMID:33451175
- PMID:33456084
- PMID:33502499
- PMID:33870531
- PMID:33961266
- PMID:34110416
- PMID:34195587
- PMID:34237007
- PMID:34247230
- PMID:34250455
- PMID:34321249
- PMID:34358107
- PMID:34379541
- PMID:34393789
- PMID:34424311
- PMID:34468689
- PMID:34501467
- PMID:34553429
- PMID:34647989
- PMID:34747511
- PMID:34785883
- Wikipedia:Baricitinib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from baricitinib
Phenotype where environments contain baricitinib
Phenotype modified by environments containing baricitinib
Human Disease Model